设为首页 加入收藏

TOP

AMOXICILLIN capsules, AMOXICILLIN for oral suspension, and AMOXICILLIN tablets (chewable)
2016-06-28 01:36:37 来源: 作者: 【 】 浏览:352次 评论:0
  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use AMOXICILLIN CAPSULES, AMOXICILLIN FOR ORAL SUSPENSION, and AMOXICILLIN TABLETS (CHEWABLE) safely and effectively. See full prescribing information for AMOXICILLIN CAPSULES, AMOXICILLIN FOR ORAL SUSPENSION, and AMOXICILLIN TABLETS (CHEWABLE).
    AMOXICILLIN capsules, AMOXICILLIN for oral suspension, and AMOXICILLIN tablets (chewable) for oral use
    Initial U.S. Approval: 1974
    RECENT MAJOR CHANGES
    Indications and Usage, Gonorrhea (1.5) Removed 9/2015

    Dosage and Administration, Gonorrhea (2.1) Removed 9/2015

    INDICATIONS AND USAGE

    Amoxicillin is a penicillin-class antibacterial indicated for treatment of infections due to susceptible strains of designated microorganisms.

    Infections of the ear, nose, throat, genitourinary tract, skin and skin structure, and lower respiratory tract. ( 1.1 to 1.4)
    In combination for treatment of H. pylori infection and duodenal ulcer disease. ( 1.5)

    To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin capsules, amoxicillin for oral suspension, amoxicillin tablets (chewable) and other antibacterial drugs, amoxicillin capsules, amoxicillin for oral suspension, and amoxicillin tablets (chewable) should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. (1.6)

    DOSAGE AND ADMINISTRATION
    In adults, 750 to 1750 mg/day in divided doses every 8 to 12 hours. In Pediatric Patients > 3 Months of Age, 20 to 45 mg/kg/day in divided doses every 8 to 12 hours. Refer to full prescribing information for specific dosing regimens. ( 2.1, 2.2, 2.3)
    The upper dose for neonates and infants ≤ 3 months is 30 mg/kg/day divided every 12 hours. ( 2.2)
    Dosing for H. pylori Infection: Triple therapy: 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily (every 12 hours) for 14 days. Dual therapy: 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily (every 8 hours) for 14 days. ( 2.3)
    Reduce the dose in patients with severe renal impairment (GFR < 30 mL/min). ( 2.4)
    DOSAGE FORMS AND STRENGTHS
    Capsules: 250 mg, 500 mg ( 3)
    Powder for Oral Suspension: 125 mg/5 mL, 250 mg/5 mL ( 3)
    Tablets (Chewable): 125 mg, 250 mg ( 3)

    CONTRAINDICATIONS

    History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or to other beta-lactams (e.g., penicillins or cephalosporins) ( 4)

    WARNINGS AND PRECAUTIONS
    Anaphylactic Reactions: Serious and occasionally fatal anaphylactic reactions have been reported in patients on penicillin therapy. Serious anaphylactic reactions require immediate emergency treatment with supportive measures. ( 5.1)
    Clostridium difficile Associated Diarrhea (ranging from mild diarrhea to fatal colitis): eva luate if diarrhea occurs. ( 5.2)
    ADVERSE REACTIONS

    The most common adverse reactions (> 1%) observed in clinical trials of amoxicillin capsules, tablets (chewable) or oral suspension were diarrhea, rash, vomiting, and nausea. (6.1)

    To report SUSPECTED ADVERSE REACTIONS, contact TEVA USA, PHARMACOVIGILANCE at 1-866-832-8537 or drug.safety@tevapharm.com; or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

    DRUG INTERACTIONS
    Probenicid decreases renal tubular secretion of amoxicillin which may result in increased blood levels of amoxicillin. ( 7.1)
    Concomitant use of amoxicillin and oral anticoagulants may increase the prolongation of prothrombin time. ( 7.2)
    Coadministration with allopurinol increases the risk of rash. ( 7.3)
    Amoxicillin may reduce the efficacy of oral contraceptives. ( 7.4)
    USE IN SPECIFIC POPULATIONS
    Pediatric: Modify dose in patients 12 weeks or younger (≤ 3 months). ( 8.4)
    See 17 for PATIENT COUNSELING INFORMATION.

    Revised: 1/2016

  • FULL PRESCRIBING INFORMATION: CONTENTS*
  • Tags: 责任编辑:admin
    】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
    分享到QQ空间
    分享到: 
    上一篇CANCIDAS (caspofungin acetate) .. 下一篇VFEND(voriconazole) for injecti..

    相关栏目

    最新文章

    图片主题

    热门文章

    推荐文章

    相关文章

    广告位